Restrictions on vitamin B6 sales


Regulator moves to strengthen safety controls around products containing vitamin B6  Supplements containing more than 50 mg of vitamin B6 per recommended daily dose will be up-scheduled to pharmacist-only, while products with a daily dose in excess of 200 mg will require a prescription from 1 June 2027.   The decision came after the Therapeutic Goods Administration (TGA) announced that the Poisons Standard for vitamin B6 had been amended following “an

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Most miss link between equity and planetary health: study
Next Headwinds hit MedAdvisor revenue